Google
 
Web www.vitaminlore.com
www.eniva.com

Triamterene

Also indexed as: Dyrenium®

Combination drugs: Dyazide®, Maxzide®

Triamterene is a potassium-sparing diuretic (i.e., it inhibits the urinary excretion of potassium). Diuretics increase urinary water loss from the body and are used to treat high blood pressure, congestive heart failure, and some kidney or liver conditions. Triamterene is available as a single agent and in combination products.

Interactions with Dietary Supplements

Calcium
A review of the research literature indicates that triamterene may increase calcium loss.1 The importance of this information is unclear.

Folic acid
Triamterene is a weak folic acid antagonist that has been associated with folic acid-deficiency anemia in people already at risk for folic acid deficiency.2 However, people treated long term with triamterene, without additional risk for folic acid deficiency, were found to have normal folic acid levels and no signs of folic acid deficiency.3 The use of multivitamin supplements containing folic acid appears to diminish the occurrence of birth defects associated with triamterene. According to one study,4 pregnant women who took folic acid–containing multivitamin supplements in addition to their prescription drugs had fewer babies with heart defects and deformities of the upper lip and mouth.

One study showed that people taking diuretics for more than six months had dramatically lower blood levels of folic acid and higher levels of homocysteine compared with individuals not taking diuretics.5 Homocysteine, a toxic amino acid byproduct, has been associated with atherosclerosis. Until further information is available, people taking diuretics for longer than six months should probably supplement with folic acid.

Magnesium
Preliminary research in animals suggests that triamterene may inhibit the urinary excretion of magnesium.6 It is unknown if this same effect would occur in humans. Persons taking more than 300 mg of magnesium per day and triamterene should consult with a doctor as this combination may lead to potentially dangerous increases in the level of magnesium in the body. The combination of triamterene and hydrochlorothiazide would likely eliminate this problem, as hydrochlorothiazide may deplete magnesium.

Potassium
As a potassium-sparing drug, triamterene reduces urinary loss of potassium, which can lead to elevated potassium levels.7 People taking triamterene should avoid potassium supplements, potassium-containing salt substitutes (Morton Salt Substitute®, No Salt®, Lite Salt®, and others) and even high-potassium foods (primarily fruit). Doctors should monitor potassium blood levels in patients taking triamterene to prevent problems associated with elevated potassium levels.

Sodium
Diuretics, including triamterene, cause increased loss of sodium in the urine. By removing sodium from the body, diuretics also cause water to leave the body. This reduction of body water is the purpose of taking diuretics. Therefore, there is usually no reason to replace lost sodium, although strict limitation of salt intake in combination with the actions of diuretics can sometimes cause excessive sodium depletion. On the other hand, people who restrict sodium intake and in the process reduce blood pressure may need to have their dose of diuretics lowered. People taking triamterene should talk with their prescribing doctor before severely restricting salt.

Interactions with Herbs

Diuretic herbs
Herbs that have a diuretic effect should be avoided when taking diuretic medications, as they may enhance the effect of these drugs and lead to possible cardiovascular side effects. These herbs include dandelion, uva ursi, juniper, buchu, cleavers, horsetail, and gravel root.8

Interactions with Foods and Other Compounds

Food
Triamterene is best taken after meals to avoid stomach upset.9

Summary of Interactions for Triamterene

Depletion or interference Calcium*
Folic acid*
Adverse interaction Buchu
Cleavers
Dandelion
Gravel root
Horsetail
Juniper
Magnesium
Potassium
Uva ursi
Side effect reduction/prevention Folic acid
Supportive interaction None known
Reduced drug absorption/bioavailability None known
Other (see text) Sodium

For the convenience of the reader, the information in the summary is categorized as follows: “Depletion or interference” indicates the drug may deplete or interfere with the absorption or function of the supplement or herb. “Adverse interaction” indicates that the supplement or herb used together with the drug may result in undesirable effects. “Side effect reduction/prevention” indicates the supplement or herb may reduce the likelihood and/or severity of a potential side effect caused by the drug. “Supportive interaction” indicates the supplement or herb may support or aid the function of the drug. “Reduced drug absorption/bioavailability” indicates that the supplement or herb may decrease the absorption and/or activity of the drug in the body. An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.

References:

1. Werbach WR. Foundations of Nutritional Medicine. Tarzana, CA: Third Line Press, 1997, 246 [review].

2. Jackson EK. Diuretics. In Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw Hill, 1996, 706.

3. Mason JB, Zimmerman J, Otradovec CL, et al. Chronic diuretic therapy with moderate doses of triamterene is not associated with folate deficiency. J Lab Clin Med 1991;117:365–9.

4. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000;343:1608–14.

5. Morrow LE, Grimsley EW. Long-term diuretic therapy in hypertensive patients: effects on serum homocysteine, vitamin B6, vitamin B12, and red blood cell folate concentrations. South Med J 1999;92:866–70.

6. Devane J, Ryan MP. The effects of amiloride and triamterene on urinary magnesium excretion in conscious saline-loaded rats. Br J Pharmacol 1981;72:285–9.

7. Jackson PR, Ramsay LE, Wakefield V. Relative potency of spironolactone, triamterene and potassium chloride in thiazide-induced hypokalaemia. Br J Clin Pharmacol 1982;14:257–63.

8. Brinker F. Herb Contraindications and Drug Interactions. Sandy, OR: Eclectic Institute, 1997, 102–3.

9. Threlkeld DS, ed. Diuretics and Cardiovasculars, Potassium-Sparing Diuretics, Triamterene. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, Jul 1993, 138k–9.